Dergiler / Turkish Journal of Urology / 2021 / Cilt: 47 - Sayı: 1

Renal tumor growth rate in patients with previously normal CT scan: Analysis of the initial stage of growth

Sayfa
9–13
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

We found the highest LGR published up to date.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Most of the studies regarding natural history of renal masses are based on active surveillance series and suggest that the renal masses have a slow growth rate.
📊
Temel Bulgular & Veri:We aimed to analyze the growth rate in newly diagnosed kidney tumors.
💡
Sonuç & Katkı:We found the highest LGR published up to date.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: Most of the studies regarding natural history of renal masses are based on active surveillance series and suggest that the renal masses have a slow growth rate. Nevertheless, only a few studies report the time between a normal computed tomography (CT) scan to the first detection of a tumor. We aimed to analyze the growth rate in newly diagnosed kidney tumors. Material and methods: We analyzed patients with enhancing renal masses that developed after a normal CT scan, which was performed at most 12 months earlier. Variables examined included patient age, gender, tumor size, volume, tumor linear growth rate (LGR). All cases were surgically treated. Mann–Whitney U test was used to compare variables. A p<0.05 was considered as statistically significant. Results: We found 31 patients with 33 lesions. Male to female ratio was 1.58 (19/12). The average age was 59.2 years (standard deviation [SD]±12.1), and the mean tumor size was 4.27 cm (SD±4.3). Tumor LGR was 0.87 cm/month (range: 0.28–1.66) and presumed to be 10.4 cm at 1 year (range: 3.36-19.9). Tumor LGR for time detection at <6 month or ≥6 months were 1.1 cm/month and 0.68 cm/month (range: 0.27–1.08 and 0.88–1.76, respectively; p=0.0004), respectively. Tumor LGRs for low- and high-grade tumors were 0.89 cm/month and 0.83 cm/month (p=0.65), respectively. Median volume was 36.1 cm³ (range: 2.61–143.7), and for low and high grade the median volumes were 27.9 cm³ and 47.6 cm³, respectively (p=0.54). Malignant pathology was present in 93.9 % (31 of 33) of masses (lesions). Conclusion: We found differences in tumor LGR in tumors detected before and after 6 months. We did not find any correlation between tumor growth rate and Fuhrman grade system, gender, histology, or age. We found the highest LGR published up to date.

🔖

Bu Makaleye Atıf Yap

AMERİ, C., PİTA, H. R., VİTAGLİANO, G., BLAS, L. (2021). Renal tumor growth rate in patients with previously normal CT scan: Analysis of the initial stage of growth. Turkish Journal of Urology, Cilt: 47 - Sayı: 1, 9–13. https://ajindex.com/articles/411566

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG. The natural history of observed enhancing renal masses: metaanalysis and review of the world literature. J Urol 2006
  2. [Crossref] 2. Kane CJ, Mallin K, Ritchey J, Cooperberg MR, Carroll PR. Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer 2008
  3. [Crossref] 3. Pantuck AJ, Zisman A, Belldegrun AS. The changing natural history of renal cell carcinoma. J Urol 2001
  4. [Crossref] 4. Volpe A. The role of active surveillance of small renal masses. Int J Surg 2016
  5. [Crossref] 5. Bosniak MA. Observation of small incidentally detected renal masses. Semin Urol Oncol 1995
  6. Rendon RA, Stanietzky N, Panzarella T, Robinette M, Klotz LH, Thurston W, et al. The natural history of small renal masses. J Urol 2000
  7. [Crossref] 7. Mason RJ, Abdolell M, Trottier G, Pringle C, Lawen JG, Bell DG, et al. Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance. Eur Urol 2011
  8. [Crossref] 8. Organ M, Jewett M, Basiuk J, Morash C, Pautler S, Siemens DR, et al. Growth kinetics of small renal masses: a prospective analysis from the Renal Cell Carcinoma Consortium of Canada. Canad Urol Assoc J 2014
  9. [Crossref] 9. Crispen PL, Viterbo R, Fox EB, Greenberg RE, Chen DY, Uzzo RG. Delayed intervention of sporadic renal masses undergoing active surveillance. Cancer 2008
  10. [Crossref] 10. Mitchell TJ, Turajlic S, Rowan A, Nicol D, Farmery JHR, O'Brien T, et al. Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal. Cell 2018
  11. e17. [Crossref] 11. Abou Youssif T, Kassouf W, Steinberg J, Aprikian AG, Laplante MP, Tanguay S. Active surveillance for selected patients with renal masses: updated results with longterm follow-up. Cancer 2007
  12. [Crossref] 12. Smaldone MC, Kutikov A, Egleston BL, Canter DJ, Viterbo R, Chen DY, et al. Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis. Cancer 2012
  13. [Crossref] 13. Cheung DC, Finelli A. Active Surveillance in Small Renal Masses in the Elderly: A Literature Review. Eur Urol Focus 2017
  14. [Crossref] 14. Zhang L, Li XS, Zhou LQ. Natural history of small renal masses. Chin Med J (Engl) 2015
  15. [Crossref] 15. Kunkle DA, Crispen PL, Chen DY, Greenberg RE, Uzzo RG. Enhancing renal